Does UMBRALISIB Cause Product dose omission issue? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Product dose omission issue have been filed in association with UMBRALISIB. This represents 4.1% of all adverse event reports for UMBRALISIB.
12
Reports of Product dose omission issue with UMBRALISIB
4.1%
of all UMBRALISIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product dose omission issue From UMBRALISIB?
Of the 12 reports, 3 (25.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMBRALISIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does UMBRALISIB Cause?
Diarrhoea (47)
Nausea (36)
Disease progression (30)
Fatigue (30)
Covid-19 (16)
Nervous system disorder (15)
Death (14)
Asthenia (13)
Off label use (13)
Anaemia (11)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which UMBRALISIB Alternatives Have Lower Product dose omission issue Risk?
UMBRALISIB vs UMECLIDINIUM
UMBRALISIB vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMBRALISIB vs UMIFENOVIR
UMBRALISIB vs UNSPECIFIED INGREDIENT
UMBRALISIB vs UPADACITINIB